Designing Longevity
Skip to main content
Testosterone (TRT)

Maximus

Fertility-preserving oral TRT with enclomiphene; published clinical study, but F rating with unanswered complaints

Reviewed by Designing Longevity Editorial · last fact-checked May 1, 2026

3.1

out of 5

No financial relationship with Maximus. Editorial inclusion only.

Visit Maximus

Verdict in one glance

Best for

  • Users specifically wanting fertility-preserving TRT

    The Oral T + Enclomiphene protocol preserves LH/FSH within normal ranges, unlike traditional injectable TRT which suppresses both. For younger men, men actively trying to conceive, or men who want to preserve testicular function while raising testosterone levels, this is the differentiated option in our cohort.

  • Users who weight published-clinical-study evidence

    Maximus is the only hormone-TRT provider in our cohort with publicly-documented clinical study results on its specific protocol. For users who specifically want clinical-evidence transparency from their telehealth provider, this is a meaningful differentiator.

Look elsewhere if

  • Users on traditional injectable TRT

    Maximus's protocol is oral testosterone + enclomiphene, not the standard intramuscular or subcutaneous testosterone protocol most TRT users are familiar with. Hone Health, Defy Medical, or Marek Health are the cohort options for traditional injectable TRT.

  • Users who weight BBB complaint posture at all

    The F driven by unanswered complaints is a meaningful operational signal. If responsive customer service and clean cancellation flow matter to you, this is a real concern. Hone Health (BBB Accredited) is the cohort default for users who weight BBB signals.

Our take

Maximus is the only TRT provider in our cohort with a publicly-documented clinical study on its specific protocol (4x total testosterone and 5x free testosterone with LH/FSH preserved on the Oral T + Enclomiphene approach), which is a meaningful clinical-transparency advantage. The fertility-preservation angle is also genuinely differentiating for younger men or those concerned about fertility on traditional injectable TRT. Honest counterweights are real and stack: F rating driven by unanswered complaints (structurally similar to Henry Meds's failure mode), small sample relative to cohort competitors, and a broader -medication footprint that extends beyond TRT into and other categories. Choose Maximus if fertility-preserving oral TRT is specifically the binding need and you've read the BBB complaint pattern and decided you're comfortable with the operational risk; otherwise Hone Health remains the cleaner default for hormone-TRT.

Pros

  • Only TRT provider in our cohort with a publicly-documented clinical study on its specific protocol
  • Fertility-preserving Oral T + Enclomiphene protocol (LH/FSH preserved within normal ranges)
  • $99.99/mo enclomiphene-only is the lowest TRT entry point in our cohort
  • 4.4-4.6/5 with no fraud notice (smaller sample than cohort leaders)
  • No ; no active manufacturer lawsuits
  • Published protocol whitepapers and study results on the public site

Cons

  • F rating with documented unanswered complaints (repeat charges without delivery, refund refusals)
  • Two profiles for the same operating company (Maximus Tribe and Maximus Health, Inc.) in unusual vitamins-and-supplements category
  • Small sample (200-260) relative to Hone Health (10,000+)
  • Annual-commitment pricing structure means month-to-month users pay more than headline rates
  • Broader footprint ( weight loss, oxytocin calming cream, etc.) adds vendor exposure
  • ExcelMale forum threads document recurring communication friction with the platform

Pricing

$99.99/mo enclomiphene-only or $199.99/mo oral testosterone + enclomiphene (annual commitment)

Turnaround

Initial labs + clinician review before Rx; same-week turnaround

States served

All 50

Last verified

May 1, 2026

What Maximus says, and what we found

The provider's own marketing claims, paired with our verdict. Color-coded so you can scan: green for verified, amber for stated-but-unconfirmed, violet for context.

VerifiedCare model

Confirmed against the public study review page. The published-clinical-study transparency is genuinely differentiated in our hormone-TRT cohort.

Maximus Tribe published clinical study results showing 4x total testosterone and 5x free testosterone with LH/FSH preserved on the Oral T + Enclomiphene protocol.

Maximus Tribe clinical study review · captured May 1, 2026 · source

VerifiedPricing

Confirmed. Lowest TRT entry point in our cohort. Annual-commitment structure required for the headline rate.

Enclomiphene-only protocol $99.99/month with annual commitment.

Maximus Tribe pricing · captured May 1, 2026 · source

Rubric breakdown

How this is scored

Licensure

20% weight
3.5/5

Active state license, no recent disciplinary actions, no FDA enforcement.

No on Maximus Health, Inc. or Maximus Tribe verified at capture date. No active manufacturer lawsuits. Operating entity is unusual: carries two profiles (Maximus Tribe and Maximus Health, Inc., both Santa Monica, both vitamins-and-supplements category) which suggests the company has not pursued a unified medical-services BBB categorization typical of other TRT cohort providers.

What we verified (3)

  • No FDA warning letter on Maximus / Maximus Tribe / Maximus Health

    Federal database

    Checked May 1, 2026 · source

  • Maximus Tribe BBB profile (Santa Monica, CA)

    Business filing

    Vitamins-and-supplements category in Santa Monica. The unusual category placement (vs telemedicine or clinic) is itself a softer signal about how the company has positioned itself with the .

    Checked May 1, 2026 · source

  • Maximus Health, Inc. BBB profile (Santa Monica, CA)

    Business filing

    Separate profile for the operating-entity name, also in Santa Monica, also vitamins-and-supplements category. The dual-profile setup is unusual; consolidates vs splits depending on how readers search.

    Checked May 1, 2026 · source

Accreditation

20% weight
1.5/5

PCAB, LegitScript, NABP, USP <797> stack.

F rating, NOT Accredited. The F is driven by unanswered complaints, structurally similar to Henry Meds's failure mode in our cohort. Multiple BBB complaints document repeat charges without medication delivery, refused refunds, and unanswered cancellation requests. not independently confirmable on a public registry. Tied with Henry Meds for the worst accreditation posture across our entire marketplace cohort.

What we verified (2)

  • BBB rating: F, NOT Accredited

    Accreditation

    F is the lowest grade. Driven by unanswered complaints documenting repeat charges without medication delivery, refund refusals, and unanswered cancellation requests. The non-response rate is the responsiveness signal that drives the F grade.

    Checked May 1, 2026 · source

  • LegitScript Healthcare Merchant Certification

    Accreditation

    Not independently confirmable on a public registry. Maximus advertises through standard channels which generally requires , but we cannot point to a public source.

    Checked May 1, 2026

Transparency

20% weight
4.0/5

CoAs, ingredient sourcing, formulation disclosure.

Published clinical study results on the oral testosterone + enclomiphene protocol (4x total testosterone increase, 5x free testosterone, with LH/FSH preserved within normal ranges). Pricing tiers documented clearly. Protocol whitepapers public. The depth of clinical-evidence transparency is meaningfully stronger than the typical TRT telehealth competitor; Maximus is the only TRT provider in our cohort with a publicly-documented clinical study on its specific protocol.

What we verified (3)

  • Published clinical study on Oral T + Enclomiphene protocol

    Care-model transparency

    Clinical study results documenting 4x total testosterone and 5x free testosterone increases with the Oral TRT + Enclomiphene protocol. Average peak total T 1327 ng/dL and peak free T 38.3 ng/dL (administered with 30g fat). LH/FSH preserved within normal ranges, distinguishing the protocol from traditional injectable TRT which suppresses both.

    Checked May 1, 2026 · source

  • Tiered pricing published

    Pricing transparency

    Enclomiphene-only $99.99/mo (annual commitment). Oral Testosterone + Enclomiphene $199.99/mo (annual commitment). Range up to $399.99/mo for higher-tier protocols.

    Checked May 1, 2026 · source

  • Protocol whitepaper published

    Care-model transparency

    Checked May 1, 2026

Product quality

15% weight
3.5/5

Independent test results, recall history, supply-chain controls.

Oral testosterone + enclomiphene protocol is documented in a published clinical study and structurally different from traditional injectable testosterone TRT. The fertility-preservation angle (LH/FSH not suppressed) is genuinely differentiating for users who want to preserve testicular function while raising testosterone levels. Maximus also offers weight loss medications and other compounded products beyond TRT, which adds compounder-vendor management exposure that's worth flagging. Compounding pharmacy partners are not named per fill.

What we verified (3)

  • Oral testosterone + enclomiphene protocol with clinical study backing

    Care model

    The clinical study documenting 4x total T and 5x free T increases with LH/FSH preserved is the strongest care-model evidence in our hormone-TRT cohort. The protocol is structurally different from injectable TRT and is the central reason fertility-conscious users choose Maximus.

    Checked May 1, 2026 · source

  • Compounded medication footprint extends beyond TRT

    Vendor oversight

    Maximus offers weight loss medications, oxytocin calming cream, and other compounded protocols beyond TRT. Broader compounded footprint increases compounder-vendor management exposure during the 2025-2026 enforcement environment.

    Checked May 1, 2026

  • No FDA recalls on Maximus-distributed product

    Recall history

    Checked May 1, 2026 · source

Pricing

15% weight
4.0/5

Value within the category, no surprise fees, refund policy.

$99.99/mo for the enclomiphene-only protocol on annual commitment is the lowest entry point in our hormone-TRT cohort. $199.99/mo for the Oral Testosterone + Enclomiphene protocol is competitive with Hone Health's all-in math. Annual-commitment pricing structure means month-to-month users pay more; the annual-prepay assumption is baked into the headline numbers. Both protocols include lab testing and clinician review per the company's published materials.

What we verified (2)

  • Tiered protocol pricing published

    Pricing transparency

    Lowest TRT entry point in our cohort at $99.99/mo enclomiphene-only on annual commitment.

    Checked May 1, 2026 · source

  • Annual commitment required for headline pricing

    Pricing terms

    Headline $99.99/mo and $199.99/mo numbers assume annual commitment. Month-to-month users pay more; the commitment structure should be understood before signing up.

    Checked May 1, 2026

Customer service

10% weight
2.0/5

Refund policy, support quality, complaint history.

4.4-4.6/5 across roughly 200-260 reviews depending on which Trustpilot mirror you reach (relatively small sample for a cohort that includes Hone's 10,000+ reviews). No suspected-fraudulent-review notice. Counterweight is heavy: F rating with unanswered complaints documenting a pattern of repeat charges without medication delivery, refund refusals, and unanswered cancellation requests. The structural failure mode mirrors Henry Meds's BBB picture in the cohort.

What we verified (3)

  • Trustpilot 4.4-4.6/5 across roughly 200-260 reviews

    External review

    Smaller sample than Hone (10K+) or Defy (3.8K). No fraud notice on the page at capture date. Positives concentrate on protocol effectiveness (testosterone-level results documented in user posts) and customer service responsiveness (when contact succeeds).

    Checked May 1, 2026 · source

  • BBB F rating with unanswered complaints

    Complaint history

    F driven by unanswered complaints. Documented complaint themes: repeat charges without medication delivery, refund refusals after cancellation requests, and difficulty reaching a real person through phone or chat support.

    Checked May 1, 2026 · source

  • ExcelMale community discussion

    Forum commentary

    ExcelMale (the largest TRT-focused community forum) has multiple multi-page threads on Maximus protocols. Recurring themes: testosterone-level results consistent with the published clinical study, but communication friction with the platform for some users.

    Checked May 1, 2026 · source

Public reviews

What we found across third-party review platforms. These are external sentiment signals, not our scoring inputs.

Trustpilot

4.4-4.6/5 across roughly 200-260 reviews depending on which mirror you reach. No fraud notice on the page at capture date. Smaller sample than cohort leaders. Positives concentrate on protocol effectiveness (testosterone-level results matching the published clinical study) and educational resources. Negatives concentrate on shipment delays, communication friction, and concerns about the company moderating dissenting views on its community forum.

Captured May 1, 2026Source

Better Business Bureau

NOT Accredited. F rating driven by unanswered complaints. Vitamins-and-supplements category in Santa Monica. Documented complaint themes: repeat charges without medication delivery, refund refusals after cancellation, doctor-visit no-shows with refused refunds, difficulty reaching a real person.

Captured May 1, 2026Source

ExcelMale forum

ExcelMale (the largest TRT-focused community forum) has multi-page threads on Maximus protocols. Recurring themes: testosterone-level results consistent with the published clinical study (positive feedback on protocol effectiveness), but communication friction with the platform and difficulty reaching support.

Captured May 1, 2026Source

What to expect

  1. 1

    Protocol selection

    5-10 min

    Choose Enclomiphene-only ($99.99/mo annual) or Oral T + Enclomiphene ($199.99/mo annual). Higher-tier protocols up to $399.99/mo. Annual commitment baked into headline pricing.

  2. 2

    Initial labs

    5-10 days

    Maximus orders baseline labs (testosterone, estradiol, hematocrit, comprehensive metabolic panel). Results typically back in 5-10 days.

  3. 3

    Clinician review and Rx

    Same-week turnaround

    Board-certified physician reviews labs and protocol. If TRT is appropriate, prescription is issued and shipped from a partner compounding pharmacy. Cold-chain shipping for any injectable formulations.

  4. 4

    Ongoing membership

    Ongoing

    Annual-commitment pricing structure. complaints document a pattern of repeat charges without medication delivery and unanswered cancellation requests; if you sign up, retain documentation of every interaction in case you need to escalate.

Accreditations

State pharmacy/clinic license

Verified · May 1, 2026

LegitScript Certified

Unverified · May 1, 2026 · source

Frequently asked

Is Maximus legit?

Yes in the narrow sense: Maximus Health, Inc. (also d/b/a Maximus Tribe) is a real Santa Monica-based men's health telehealth platform with a publicly-documented clinical study on its Oral T + Enclomiphene protocol (4x total testosterone, 5x free testosterone, LH/FSH preserved within normal ranges), board-certified physicians, no , and no active manufacturer lawsuits. The clinical-evidence transparency is genuinely the strongest in our hormone-TRT cohort. Whether 'legit' means trustworthy enough for you is a different question. The F rating driven by unanswered complaints (documenting repeat charges without medication delivery, refund refusals, and unanswered cancellation requests) is a real operational signal. Choose Maximus if fertility-preserving oral TRT is specifically what you want and you've read the BBB complaint pattern; otherwise Hone Health is the cleaner default.

What's the difference between Maximus's protocol and traditional TRT?

Traditional TRT is injectable testosterone (intramuscular or subcutaneous) which raises testosterone levels but suppresses LH and FSH (the hormones that drive your body's own testosterone production and testicular function). Maximus's flagship protocol is oral testosterone plus enclomiphene, designed to raise testosterone levels while preserving LH and FSH within normal ranges. The fertility-preservation angle is the central differentiator. The enclomiphene-only protocol uses just the SERM without supplemental testosterone, which raises your body's own testosterone production over time rather than replacing it.

Why does Maximus have an F at the BBB?

F grades are driven by both complaint volume and how the business handles complaints. Maximus Tribe's F is driven specifically by unanswered complaints documenting a pattern of repeat charges without medication delivery, refund refusals after cancellation requests, and difficulty reaching a real person. The non-response rate is the part that drives the F. Maximus has two BBB profiles (Maximus Tribe and Maximus Health, Inc., both Santa Monica) which is unusual; both carry similar complaint patterns. If responsive customer service matters to you, this is a real concern.

Is the Maximus clinical study legitimate?

The study and results are published on the company's public site. The headline findings are 4x total testosterone increase, 5x free testosterone increase, with LH/FSH preserved within normal ranges, and average peak total T of 1327 ng/dL when administered with 30g fat. Maximus is the only TRT provider in our cohort with a publicly-documented clinical study on its specific protocol, which is a meaningful clinical-transparency advantage. The study was conducted by the company on its own protocol, so it is internal evidence rather than independent academic research; weight it accordingly.

How much does Maximus actually cost?

Headline rates assume annual commitment. Enclomiphene-only is $99.99/month annual commitment. Oral Testosterone + Enclomiphene is $199.99/month annual commitment. Higher-tier protocols up to $399.99/month. Initial labs are typically billed within the membership; ongoing labs may be billed separately depending on the protocol tier. Month-to-month pricing is meaningfully higher than the annual-commitment headline; understand the commitment structure before signing up given the documented complaint pattern around cancellation.

How does Maximus compare to Hone Health?

Different protocols and operational profiles. Hone Health is membership-model TRT focused on traditional injectable testosterone, Accredited since December 2023, with the strongest customer-service signals in our hormone-TRT cohort ( 4.8/5 across 10,000+ reviews) and bundled labs from month three. Maximus uses oral testosterone + enclomiphene with a fertility-preservation angle and the only published clinical study in our cohort, but with BBB F rating and a small Trustpilot sample. For traditional TRT, Hone is the cleaner choice. For fertility-preserving oral TRT, Maximus is the protocol-differentiated option, with the BBB caveat acknowledged.

Update history

Every meaningful change to this profile, with a date stamp. We don't silently re-score.

  1. May 1, 2026

    Initial published profile. Sources HEAD-checked at publish time. Score (3.1) reflects the clinical-transparency advantage (only published protocol study in our hormone-TRT cohort, fertility-preservation differentiator) weighed against the F rating with unanswered complaints, small sample, and broader footprint extending beyond TRT.

Compare Maximus head-to-head

Stuck choosing? We pick a winner per use case in the comparisons below.

vs Defy Medical

Independent head-to-head: Defy Medical vs Maximus for TRT. A 16-year MD/DO clinic vs oral testosterone with a study but a BBB F rating.

See verdict

vs Hone Health

Independent head-to-head: Hone Health vs Maximus for TRT. Injectable with the strongest trust signals vs oral enclomiphene with a BBB F rating.

See verdict

vs Marek Health

Independent head-to-head: Marek Health vs Maximus for TRT. Coaching plus prescribing vs oral enclomiphene with a BBB F rating.

See verdict

Reviewed by Designing Longevity Editorial. Last fact-checked May 1, 2026.

Spot something out of date or wrong? Let us know and we'll re-check.

Back to all providers